Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (9.838)

1681

Digital adaptation of a therapeutic education program in the context of Covid-19

enthalten in: Soins. Pediatrie, puericulture | 2023

von Bregeon, A. | Berthelot, V. | Béri, C. | +2

1682

A case of reinfection with a different variant of SARS-CoV-2 : case report

enthalten in: The Egyptian journal of internal medicine | 2023

von Shimada, N. | Shinoda, M. | Takei, H. | +7

1683

Risk Factor for Superimposed Nosocomial Bloodstream Infections in Hospitalized Patients with COVID-19

enthalten in: Infection and drug resistance | 2023

von Sathaporn, N. | Khwannimit, B.

1684

Glucocorticoids, COVID-19 and Cryptococcosis

enthalten in: Anti-inflammatory & anti-allergy agents in medicinal chemistry | 2023

von Dos Santos, W. | Rogerio, A.

1685

Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial

enthalten in: Wiener medizinische Wochenschrift | 2023

von Taher, A. | Lashkari, M. | Keramat, F. | +4

1686

Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination - an update

enthalten in: Neurologia i neurochirurgia polska | 2023

von Przytuła, F. | Sławek, J.

1687

Recurrent Acute Disseminated Encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection : A case report (part II)

enthalten in: Frontiers in neurology | 2023

von Poli, K. | Kowarik, M. | Hamprecht, K. | +4

1688

Corticosteroids in COVID-19 : pros and cons

enthalten in: Frontiers in medicine | 2023

von Bahsoun, A. | Fakih, Y. | Zareef, R. | +2

1689

The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19

enthalten in: Current pharmaceutical design | 2023

von Azimi, S. | Saghafi, F. | Mohammadi, M. | +8

1690

AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans

enthalten in: Current pharmaceutical design | 2023

von Shamkh, I. | Elkazzaz, M. | Radwan, E. | +14